POLR2A and cancer: Drugging TP53-deleted cancers had been a challenging task until a recent report demonstrated inhibition of a neighboring gene POLR2A, which is located about 200 kb downstream of TP53 on chromosome 17 and undergoes heterozygous deletion in colorectal cancers containing TP53 heterozygous deletion (Liu et al., 2015).